Polypid Ltd (PYPD) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to 0 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Polypid Ltd  (NASDAQ: PYPD)


Polypid Ltd's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Polypid Ltd's ROI in the second quarter of 2025?
Polypid Ltd achieved a return on average invested assets (ROI) of 79.5 % in its second quarter of 2025, which is below Polypid Ltd's average return on investment, which stands at 238.24%.

ROI decreased relative to the period ending Dec 31 2024, due to the decline in net income.

Within the Healthcare sector only one company had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2024 from 27 to 28.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
II. Quarter		 (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Investment Change TTM 89.99 % 29.44 % -36.04 % -72.1 % -66.48 %
Y / Y Net Income Change TTM -71.91 % -32.25 % - - -
Investment (TTM) in Millions 19 28 9 8 5
Return On Investment (TTM) 79.5 % 181.44 % -6.1 % 690.42 % 537.72 %
PYPD's Overall Ranking # 28 # 27 # 0 # 0 #
Seq. Investment Change TTM 28.05 % 67.09 % 32.38 % -32.92 % -12.77 %
Seq. Net Income Change TTM -43.9 % - - -13.87 % 35.31 %
Net Income (TTM) in Millions 13 23 0 39 45

PYPD Company Profile >> Back to PYPD Roi Comparisons >> See Annual PYPD Return On Investment



Return On Investment PYPD's Ranking
Within: No.
Industry # 2
Sector # 2
Overall # 28

Return On Investment Statistics
High Average Low
348.91 %
238.24 %
117.82 %
(Dec 31 2024)   (Dec 31 2021)







Financial Statements
Polypid Ltd's II. Quarter Investments $ 19 Millions PYPD's Balance sheet
Polypid Ltd's II. Quarter Income $ -10 Millions Quarterly PYPD's Income Statement
PYPD's Income by Division See PYPD's Income by Division


PYPD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 19 9 2 10 36
Y / Y Investment Growth 104.98 % 401.2 % -81.1 % -73.26 % -50.32 %
Net Income in Millions -34 29 24 -40 -43
Y / Y Net Income Growth - 20.59 % - - -
Annual Return On Investment -181.94 % 316.76 % 1316.52 % -409.07 % -117.82 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PYPD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PYPD's Competitors
Subscribers only: Roi for Polypid Ltd's Suppliers
Subscribers only: Return On Investment for PYPD's Customers

Other Ratios
PYPD's Roa PYPD's Inventory Turnover Ratio PYPD's Growth Rates PYPD's Dividend Statistics
PYPD's Profitability Ratios PYPD's Asset Turnover Ratio PYPD's Dividend Growth
PYPD's Roe PYPD's Valuation Ratios PYPD's Financial Strength Ratios PYPD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI
Capforce Inc   177.96 %
Emmis Acquisition Corp   140.55 %
Oak Woods Acquisition Corp  106.75 %
Coherus Oncology inc   105.87 %
Interpace Biosciences Inc   102.53 %
Rigel Pharmaceuticals Inc  92.61 %
Cytomx Therapeutics Inc   80.43 %
Seres Therapeutics Inc   75.04 %
Gridai Technologies Corp  75.01 %
Earth Science Tech Inc   74.07 %
Stablecoin Development Corporation  66.04 %
Novavax inc   56.96 %
Exelixis Inc   55.73 %
Biomx Inc  53.39 %
Adma Biologics Inc   49.11 %
Medinotec Inc   48.14 %
Abeona Therapeutics Inc   46.96 %
Synlogic Inc   46.41 %
Dariohealth Corp   45.05 %
Idexx Laboratories Inc  44.34 %
Entera Bio Ltd   43.13 %
Puma Biotechnology Inc   42.38 %
Agios Pharmaceuticals Inc   41.91 %
Siga Technologies Inc  38.92 %
Ptc Therapeutics inc   38.85 %
Mettler toledo International Inc   36.69 %
Edwards Lifesciences Corporation  35.59 %
Minerva Neurosciences Inc   34.19 %
Arcutis Biotherapeutics Inc   34.15 %
Longduoduo Co Ltd  33.92 %

Date modified: 2026-07-07T12:42:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.